What is the management approach for a patient presenting with a hydroxyzine (antihistamine) overdose?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 16, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Hydroxyzine (Antihistamine) Overdose

The management of hydroxyzine overdose requires supportive care, close monitoring, and treatment of symptoms, as there is no specific antidote available. 1

Initial Assessment and Management

  • Assess airway, breathing, and circulation (ABC) immediately upon presentation 2
  • Monitor vital signs frequently, with particular attention to blood pressure, heart rate, respiratory rate, and oxygen saturation 1
  • Obtain ECG monitoring due to risk of QT prolongation and Torsade de Pointes in hydroxyzine overdose 1
  • If the patient presents within 1-2 hours of ingestion and is alert, consider inducing vomiting or performing gastric lavage 1
  • Administer activated charcoal if the patient presents within 1 hour of ingestion and has a protected airway 2

Clinical Manifestations to Monitor

  • Hypersedation (most common manifestation) 1
  • Convulsions 1
  • Stupor 1
  • Nausea and vomiting 1
  • Hypotension (though uncommon) 1
  • QT prolongation and potential cardiac arrhythmias 1

Treatment Approach

  • Provide general supportive care with close observation of the patient 1
  • Manage hypotension with intravenous fluids and vasopressors if needed 1
  • For hypotension requiring vasopressor support, use levarterenol or metaraminol; avoid epinephrine as hydroxyzine counteracts its pressor action 1
  • Treat seizures if they occur with standard anticonvulsant therapy 2
  • For severe sedation, provide respiratory support as needed 1

Monitoring Period

  • Observe patients for at least 4-6 hours after ingestion to ensure no delayed toxicity develops 3
  • Patients who remain asymptomatic after 4-6 hours of observation may be considered for discharge if medically cleared and psychiatrically stable 3
  • Patients showing signs of toxicity require continued monitoring until symptoms resolve 3

Special Considerations

  • Hemodialysis is generally not effective for hydroxyzine overdose 1
  • If other substances were co-ingested (particularly barbiturates), hemodialysis may be indicated based on those substances 1
  • There is no practical method to quantitate hydroxyzine in body fluids or tissue after ingestion 1

Disposition

  • Patients with significant sedation, hemodynamic instability, seizures, or cardiac abnormalities require admission for continued monitoring 2
  • Psychiatric evaluation should be considered for intentional overdoses once the patient is medically stable 4
  • Asymptomatic patients with selected acute intentional ingestions may be released from medical observation in less than six hours if they remain stable 3

Pitfalls and Caveats

  • Do not use epinephrine to treat hypotension in hydroxyzine overdose as hydroxyzine counteracts its pressor action 1
  • Be aware that hydroxyzine may cause more pronounced sedation in elderly patients or those with hepatic impairment 5
  • Consider the possibility of co-ingestions, which may complicate the clinical picture and management 2
  • Remember that there is no specific antidote for hydroxyzine overdose, making supportive care the mainstay of treatment 1

References

Research

Diagnosis and management of the drug overdose patient.

American journal of therapeutics, 1997

Research

Emergency department observation of poisoned patients: how long is necessary?

Academic emergency medicine : official journal of the Society for Academic Emergency Medicine, 1999

Research

The approach to the patient with an unknown overdose.

Emergency medicine clinics of North America, 2007

Research

Hydroxyzine for generalised anxiety disorder.

The Cochrane database of systematic reviews, 2010

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.